Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Share-based Compensation (2016 - 2020)

Glucotrack's Share-based Compensation history spans 7 years, with the latest figure at $9000.0 for Q3 2020.

  • For the quarter ending Q3 2020, Share-based Compensation fell 92.6% year-over-year to $9000.0, compared with a TTM value of $22000.0 through Dec 2020, down 93.82%, and an annual FY2025 reading of $211000.0, up 21.97% over the prior year.
  • Share-based Compensation for Q3 2020 was $9000.0 at Glucotrack, down from $11000.0 in the prior quarter.
  • The five-year high for Share-based Compensation was $863794.0 in Q3 2017, with the low at -$871768.0 in Q4 2018.
  • Average Share-based Compensation over 5 years is $211718.4, with a median of $136590.0 recorded in 2019.
  • Year-over-year, Share-based Compensation surged 39287.37% in 2017 and then crashed 245.23% in 2018.
  • Tracing GCTK's Share-based Compensation over 5 years: stood at $21108.0 in 2016, then soared by 2743.7% to $600249.0 in 2017, then crashed by 245.23% to -$871768.0 in 2018, then surged by 89.01% to -$95767.0 in 2019, then soared by 109.4% to $9000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Share-based Compensation are $9000.0 (Q3 2020), $11000.0 (Q2 2020), and $2000.0 (Q1 2020).